Prostate Cancer Clinical Trials in Dallas

Showing 161-180 of 237 trials

A Study to Evaluate Serum Testosterone Levels in Patients With Metastatic Castration-Resistant Prostate Cancer

NCT02737332

The purpose of this study is to evaluate the serum testosterone levels in patients with Metastatic Castration-Resistant Prostate Cancer on SoluMatrix™ Abiraterone Acetate as Compared to Abiraterone Acetate

Prostate Cancer

Sun Pharmaceutical Industries Limited53 participantsStarted Mar 2016

Laguna Hills, California, United States • Los Angeles, California, United States • San Bernardino, California, United States +14 more locations

TERMINATEDPhase 1/2< 1 mile

Rovalpituzumab Tesirine in Delta-Like Protein 3-Expressing Advanced Solid Tumors

NCT02709889

The primary objective of this study is to assess the safety and tolerability of rovalpituzumab tesirine in subjects with specific delta-like protein 3-expressing advanced solid tumors.

Malignant MelanomaMedullary Thyroid CancerGlioblastoma+5 more

AbbVie200 participantsStarted Sep 2016

Gilbert, Arizona, United States • Scottsdale, Arizona, United States • Los Angeles, California, United States +27 more locations

A Study to Evaluate Serum Testosterone Levels in Patients With Metastatic Castration-Resistant Prostate Cancer

Rovalpituzumab Tesirine in Delta-Like Protein 3-Expressing Advanced Solid Tumors

Prostate Cancer Trials in Other Cities

Radiation Therapy and Ixabepilone in Treating Patients With High-Risk Stage III Prostate Cancer After Surgery

Prostate Cancer Intervention Versus Observation Trial (PIVOT)

Safety Study of BPX-201 Dendritic Cell Vaccine Plus AP1903 in Metastatic Castrate Resistent Prostate Cancer

Positive Imaging Study for Distant Metastases in Patients With Castration-Resistant Prostate Cancer

Immune Monitoring Protocol in Men With Prostate Cancer Enrolled in a Clinical Trial of Sipuleucel-T

Radiation Therapy in Treating Patients With Stage II or Stage III Prostate Cancer

Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer

AZD5153 in Patients With Relapsed or Refractory Solid Tumors, Including Lymphomas

Hormone Therapy Plus Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Prostate Cancer

Use of Recombinant Adenovirus Therapy to Treat Localized Prostate Cancer

Vinflunine in Hormone Refractory Prostate Cancer (HRPC)

Study of RV001V in Biochemical Failure Following Curatively Intended Therapy For Localized Prostate Cancer

Study of the Effect of GTx-758 on Serum PSA and Testosterone in Men With Prostate Cancer

Genetic Analysis of Hereditary Prostate Cancer

TroVax® In Subjects With Hormone Refractory Prostate Cancer (HRPC)

Efficacy and Safety of Patupilone in Men (≥18 Years) With Metastatic Hormone Refractory Prostate Cancer

A Study to Describe Patterns of Care and Outcomes of Men Who Are at High Risk After Experiencing Biochemical Failure Following Definitive Prostate Cancer Therapy, Men With Castration-resistant Prostate Cancer and Men With Metastatic Prostate Cancer

Phase 1/1b Study to Evaluate the Safety and Tolerability of Ciforadenant Alone and in Combination With Atezolizumab in Advanced Cancers

Other Conditions in Dallas